PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084677
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084677
Absorbable Hemostat Market, By Product Type, By Formulation, By Application, By End User, By Geography
Absorbable Hemostat Market is estimated to be valued at USD 3.24 Bn in 2026 and is expected to reach USD 5.31 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.24 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.30% | 2033 Value Projection: | USD 5.31 Bn |
Absorbable hemostat is a significant market within the surgical and wound care sector and involves biodegradable products used to prevent blood loss during surgical procedures that get naturally absorbed by the body after the surgery is completed. This approach obviates post-operative retrieval, simplifies procedures and aids patient recovery. Gelatin, collagen, cellulose and synthetic polymers are used to make these hemostats, and differ from each other depending on their suitability in certain procedures.
Increasing surgical procedure numbers coupled with rising incidences of chronic diseases in patients necessitates surgery and geriatric populations further propel the growth of the absorbable hemostat market. Technological advancements in hemostats that often include combination hemostats with varying modes of actions to enhance their effectiveness in various procedures are a major driver for their enhanced use. Additionally, increased use of modern surgery equipment by surgeons to enhance the outcome of surgery in minimum time frames aids in augmenting the growth of the market.
Market Dynamics
The global absorbable hemostat market is fueled by the rising number of surgical procedures conducted globally, backed by the growing incidences of diseases such as cardiovascular disorders, cancer, trauma injuries and chronic disorders. The ever-increasing utilization of minimally invasive surgical procedures, ongoing technological development of hemostatic agents in the forms of flowable and combination hemostats further spur the growth of the market. In addition, rising health expenditure and growing infrastructure for healthcare in developing economies.
The market is constrained by the high cost of absorbable hemostats in comparison with the other traditional bleeding control products and by extensive and critical regulatory compliances required for new product launch. However, risks of negative responses on few patients and restrictions in reimbursement in certain region can impact the growth. Nevertheless, the opportunities for high-growth is in the development of newer hemostats, expansion to emerging markets with higher growth prospects and increased investment on innovative biomaterials and bioengineered products for better surgical outcomes
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global absorbable hemostat market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Johnson & Johnson MedTech, Baxter International Inc., Becton, Dickinson and Company, Pfizer Inc., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Artivion, Inc., Biocer Entwicklungs-GmbH, Samyang Biopharmaceuticals Corporation, and Aegis Lifesciences Pvt. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global absorbable hemostat market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global absorbable hemostat market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Gelatin-Based Hemostats
- Oxidized Regenerated Cellulose (ORC) Hemostats
- Collagen-Based Hemostats
- Combination Hemostats
- Formulation Insights (Revenue, USD Bn, 2021 - 2033)
- Sponge
- Powder
- Matrix and Gel
- Sheet and Pad
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- General Surgery
- Cardiovascular Surgery
- Orthopedic Surgery
- Neurosurgery
- Gynecological Surgery
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Specialty Clinics
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Johnson & Johnson MedTech
- Baxter International Inc.
- Becton, Dickinson and Company
- Pfizer Inc.
- Teleflex Incorporated
- Integra LifeSciences Holdings Corporation
- Artivion, Inc.
- Biocer Entwicklungs-GmbH
- Samyang Biopharmaceuticals Corporation
- Aegis Lifesciences Pvt. Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Absorbable Hemostat Market, By Product Type
- Global Absorbable Hemostat Market, By Formulation
- Global Absorbable Hemostat Market, By Application
- Global Absorbable Hemostat Market, By End User
- Global Absorbable Hemostat Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Absorbable Hemostat Market, By Product Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Gelatin-Based Hemostats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Oxidized Regenerated Cellulose (ORC) Hemostats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Collagen-Based Hemostats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Combination Hemostats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Absorbable Hemostat Market, By Formulation, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Sponge
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Matrix and Gel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sheet and Pad
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Absorbable Hemostat Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- General Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cardiovascular Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Orthopedic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Neurosurgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Gynecological Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Absorbable Hemostat Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ambulatory Surgical Centers (ASCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Absorbable Hemostat Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Johnson & Johnson MedTech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teleflex Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integra LifeSciences Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Artivion, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biocer Entwicklungs-GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Samyang Biopharmaceuticals Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aegis Lifesciences Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
